Agilon Health reported Q2 2024 revenue of $1.5B, missed analyst consensus of $1.5B by $58.9M. Diluted EPS came in at $-0.07.
Trailing eight quarters through Q2 2024
Common questions about Agilon Health's Q2 2024 earnings report.
Agilon Health (AGL) reported Q2 2024 earnings on August 6, 2024 after market close.
Agilon Health reported revenue of $1.5B and diluted EPS of $-0.07 for Q2 2024.
Revenue missed the consensus estimate of $1.5B by $58.9M. EPS beat the consensus estimate of $-0.07 by $0.00.
You can read the 10-Q periodic report (0001628280-24-035179) directly on SEC EDGAR. The filing index links above go to sec.gov.